ResMed | RMD - Ebit

ResMed reported $288.61M in EBIT for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebit Change
Ansell ANN:AU USD 93M 53M
Cochlear COH:AU AUD 195M 23.4M
CSL CSL:AU USD 2.22B 1.34B
Estia Health EHE:AU AUD -16759000 31.1M
Fisher & Paykel Healthcare FPH:AU NZD 126.7M 76.5M
Healius Ltd HLS:AU AUD 39.4M 75.5M
Integral Diagnostics Ltd IDX:AU AUD 17.34M 240K
Mayne Pharma MYX:AU AUD -112766000 77.37M
Nanosonics Ltd NAN:AU AUD 10.49M 12.48M
Opthea Ltd OPT:AU USD -77847050 20.61M
Polynovo Ltd PNV:AU AUD -3524250 1.83M
Ramsay Health Care RHC:AU AUD 284M 175.5M
Regis Healthcare REG:AU AUD -2976000 26.01M
ResMed RMD:AU USD 288.61M 31.34M
Sigma Healthcare Ltd SIG:AU AUD 13.31M 4.9M
Sonic Healthcare SHL:AU AUD 578.99M 369.26M
Telix Pharmaceuticals Ltd TLX:AU AUD -21620000 47.57M